Deals
Valeant Said to Have Rejected Approach From Takeda-Led Group
- Drugmaker approached about six weeks ago, no talks ongoing
- New CEO Papa said this week company has ‘very good pipeline’
Valeant Rejects Takeda-TPG Takeover: Report
This article is for subscribers only.
Valeant Pharmaceuticals International Inc. received a takeover approach about six weeks ago from a group led by Takeda Pharmaceutical Co., according to people familiar with the situation.
The approach was rejected and no talks are currently ongoing, the people said, asking not to be identified as the matter is private.